BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31359124)

  • 41. The Relationship between Breast Cancer Subtypes, Prognostic Factors, and Apparent Diffusion Coefficient Histogram Analysis.
    Aktas E; Uylar Seber T; Seber T; Burcek NV; Akay E; Arslan A; Karagöz Eren S; Ozhan N; Yaltırık Bilgin E; Savran B; Akdur P
    Curr Med Imaging; 2024; 20(1):e15734056271069. PubMed ID: 38616751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diffusion tensor imaging and diffusion-weighted imaging on axillary lymph node status in breast cancer patients.
    Kurt N; Binboga Kurt B; Gulsaran U; Uslu B; Celik AO; Sut N; Tastekin E; Karabulut D; Tuncbilek N
    Diagn Interv Radiol; 2022 Jul; 28(4):329-336. PubMed ID: 35950277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging.
    Mussurakis S; Buckley DL; Horsman A
    Radiology; 1997 May; 203(2):317-21. PubMed ID: 9114081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of preoperative breast magnetic resonance imaging with a dedicated axillary sequence for the detection of axillary lymph node metastasis in patients with early ductal breast cancer.
    Ahn HS; Jang M; Kim SM; La Yun B; Lee SH
    Radiol Med; 2019 Dec; 124(12):1220-1228. PubMed ID: 31422573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of apparent diffusion coefficient values and peritumoral edema with pathologic biomarkers in patients with breast cancer.
    Moradi B; Gity M; Etesam F; Borhani A; Ahmadinejad N; Kazemi MA
    Clin Imaging; 2020 Dec; 68():242-248. PubMed ID: 32911312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
    Karan B; Pourbagher A; Torun N
    J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging.
    Giannotti E; Waugh S; Priba L; Davis Z; Crowe E; Vinnicombe S
    Eur J Radiol; 2015 Sep; 84(9):1729-36. PubMed ID: 26078100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion-weighted MRI at 3.0 Tesla.
    Park SH; Choi HY; Hahn SY
    J Magn Reson Imaging; 2015 Jan; 41(1):175-82. PubMed ID: 24353241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Region of interest demarcation for quantification of the apparent diffusion coefficient in breast lesions and its interobserver variability.
    Nogueira L; Brandão S; Matos E; Nunes RG; Ferreira HA; Loureiro J; Ramos I
    Diagn Interv Radiol; 2015; 21(2):123-7. PubMed ID: 25698095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between existence of lymphatic invasion in peritumoral breast tissue and presence of axillary lymph node metastasis in invasive ductal carcinoma of the breast.
    Kurosumi M; Suemasu K; Tabei T; Inoue K; Matsumoto H; Sugamata N; Higashi Y
    Oncol Rep; 2001; 8(5):1051-5. PubMed ID: 11496315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two Different Methods of Region-of-Interest Placement for Differentiation of Benign and Malignant Breast Lesions by Apparent Diffusion Coefficient Value.
    Gity M; Moradi B; Arami R; Arabkheradmand A; Kazemi MA
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2765-2770. PubMed ID: 30360604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic Performance of Dedicated Axillary T2- and Diffusion-weighted MR Imaging for Nodal Staging in Breast Cancer.
    Schipper RJ; Paiman ML; Beets-Tan RG; Nelemans PJ; de Vries B; Heuts EM; van de Vijver KK; Keymeulen KB; Brans B; Smidt ML; Lobbes MB
    Radiology; 2015 May; 275(2):345-55. PubMed ID: 25513854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
    Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3.0T DW-MRI: A potential predictor for an oncotype Dx test recurrence score.
    Thakur SB; Durando M; Milans S; Cho GY; Gennaro L; Sutton EJ; Giri D; Morris EA
    J Magn Reson Imaging; 2018 Feb; 47(2):401-409. PubMed ID: 28640531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
    BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apparent diffusion coefficient magnetic resonance imaging (ADC-MRI) in the axillary breast cancer lymph node metastasis detection: a narrative review.
    De Cataldo C; Bruno F; Palumbo P; Di Sibio A; Arrigoni F; Clemente A; Bafile A; Gravina GL; Cappabianca S; Barile A; Splendiani A; Masciocchi C; Di Cesare E
    Gland Surg; 2020 Dec; 9(6):2225-2234. PubMed ID: 33447575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the diagnostic performance of apparent diffusion coefficient (ADC) values on diffusion-weighted magnetic resonance imaging (DWI) in differentiating between benign and metastatic lymph nodes in cases of cholangiocarcinoma.
    Promsorn J; Soontrapa W; Somsap K; Chamadol N; Limpawattana P; Harisinghani M
    Abdom Radiol (NY); 2019 Feb; 44(2):473-481. PubMed ID: 30151713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.